Repligen
RGEN
#2056
Rank
NZ$17.06 B
Marketcap
NZ$302.33
Share price
-1.04%
Change (1 day)
49.82%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2026 (TTM): NZ$0.13 Billion

According to Repligen 's latest financial reports the company's current earnings are NZ$0.76 Billion. In 2025 the company made an earning of NZ$0.14 Billion, an increase over its 2024 earnings that were of -NZ$11.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.13 B-9.46%
2025 NZ$0.14 B-1430.84%
2024 -NZ$11.03 Million-113.01%
2023 NZ$84.71 M-78.01%
2022 NZ$0.38 B33.37%
2021 NZ$0.28 B131.52%
2020 NZ$0.12 B101.31%
2019 NZ$61.97 M25.93%
2018 NZ$49.21 M105.61%
2017 NZ$23.93 M-11.46%
2016 NZ$27.03 M14.91%
2015 NZ$23.52 M20.26%
2014 NZ$19.56 M-51.49%
2013 NZ$40.32 M90.98%
2012 NZ$21.11 M
2010 NZ$0.3 M-103.81%
2009 -NZ$8.03 Million-223.84%
2008 NZ$6.47 M
2006 -NZ$4.36 Million229.64%
2005 -NZ$1.32 Million-89.16%
2004 -NZ$12.18 Million-16.86%
2003 -NZ$14.65 Million88.72%
2002 -NZ$7.77 Million-27.88%
2001 -NZ$10.77 Million-1.74%
2000 -NZ$10.96 Million85.93%
1999 -NZ$5.9 Million159.16%
1998 -NZ$2.28 Million85.71%
1997 -NZ$1.23 Million-70.83%
1996 -NZ$4.2 Million-72.41%
1995 -NZ$15.22 Million-60.63%
1994 -NZ$38.65 Million45.39%
1993 -NZ$26.58 Million39.45%
1992 -NZ$19.06 Million-32.3%
1991 -NZ$28.16 Million6.62%
1990 -NZ$26.41 Million1577.78%
1989 -NZ$1.58 Million-57.14%
1988 -NZ$3.68 Million-362.5%
1987 NZ$1.39 M-130.77%
1986 -NZ$4.55 Million136.36%
1985 -NZ$1.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.51 B 13,468.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$12.97 B 9,408.92%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$20.02 B 14,569.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.78 B 12,195.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.2 Billion-241.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-NZ$0.12 Billion-182.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.39 B 923.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.27 B 100.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.67 B 394.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-NZ$0.29 Billion-311.94%๐Ÿ‡บ๐Ÿ‡ธ USA